CNMD as reported
CONMED Corporation reported $1.37B of revenue over the trailing twelve months, +5.2% on the year before. 11 reported series are charted on this page, each one as filed.
$1.37B
Revenue, trailing twelve months · to Q4 2025 · +5.2% against the twelve months before
- Net Income
- $47M
Net Income · −64% year on year · trailing twelve months to Q4 2025
- Free Cash Flow
- $151M
Free Cash Flow · −2.0% year on year · trailing twelve months to Q4 2025
- Op Margin
- 7.4%
Op Margin · trailing twelve months to Q4 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.37B | +5.2% | Q4 2025 |
| Net Income | $47M | −64% | Q4 2025 |
| EPS | $1.51 | −64% | Q4 2025 |
| Gross Margin | 54% | n/a | Q4 2025 |
| Op Margin | 7.4% | n/a | Q4 2025 |
| Net Margin | 3.4% | n/a | Q4 2025 |
| ROE | 8.5% | n/a | Q4 2025 |
| ROA | 3.7% | n/a | Q4 2025 |
| ROIC | 6.2% | n/a | Q4 2025 |
| Free Cash Flow | $151M | −2.0% | Q4 2025 |
| P/E | 33.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
CONMED Corporation (CNMD) - Revenue & ProfitRevenue & ProfitCONMED Corporation (CNMD)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
The closest names by size in the same industry